XML 19 R7.htm IDEA: XBRL DOCUMENT v3.4.0.3
Interim Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows from operating activities:    
Net income before noncontrolling interests $ 76,597 $ 102,390 [1],[2],[3]
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for loan losses 33,341 6,452
Provision for unfunded credit commitments 134 2,263
Changes in fair values of derivatives, net 842 (20,404)
Losses (gains) on investment securities, net 4,684 (33,263) [4]
Depreciation and amortization 11,536 9,892 [3]
Amortization of premiums and discounts on investment securities, net 4,931 6,418
Amortization of share-based compensation 6,877 7,771
Amortization of deferred loan fees (24,042) (21,169)
Pre-tax net gain on SVBIF sale transaction 0 (887)
Deferred income tax (benefit) expense (5,982) 1,311
Changes in other assets and liabilities:    
Accrued interest receivable and payable, net (4,628) 772
Accounts payable and receivable, net 552 (9,141)
Income tax payable and receivable, net 28,711 9,283 [3]
Accrued compensation (101,241) (74,614)
Foreign exchange spot contracts, net 9,541 33,934
Other, net 14,208 32,198
Net cash provided by operating activities 56,061 53,206 [3]
Cash flows from investing activities:    
Purchases of available-for-sale securities 0 (552,573)
Proceeds from sales of available-for-sale securities 1,864,396 5,612
Proceeds from maturities and pay downs of available-for-sale securities 364,101 424,713
Purchases of held-to-maturity securities (98,199) (739,291)
Proceeds from maturities and pay downs of held-to-maturity securities 351,834 336,511
Purchases of non-marketable and other securities 12,412 9,924
Proceeds from sales and distributions of non-marketable and other securities 9,977 45,120
Net increase in loans (997,408) (53,886)
Proceeds from recoveries of charged-off loans 5,469 1,551
Effect of deconsolidation of noncontrolling interest 0 15,995
Purchases of premises and equipment (13,680) (12,038)
Net cash provided by (used for) investing activities 1,474,078 (538,210)
Cash flows from financing activities:    
Net decrease in deposits (383,055) (491,924)
Net (decrease) increase in short-term borrowings (774,900) 69,985
(Distributions to noncontrolling interests), net of contributions from noncontrolling interests (2,524) 703
Tax benefit from stock exercises (8,483) 2,534
Proceeds from issuance of common stock, ESPP, and ESOP 4,078 10,107
Proceeds from issuance of 3.50% Senior Notes 0 346,431
Net cash used for financing activities (1,164,884) (62,164)
Net increase (decrease) in cash and cash equivalents 365,255 (547,168)
Cash and cash equivalents at beginning of period 1,503,257 1,811,014 [3],[5]
Cash and cash equivalents at end of period 1,868,512 1,263,846 [3],[5]
Cash and cash equivalents, including discontinued operations, at beginning of period 1,503,257  
Cash and cash equivalents, including discontinued operations, at end of period 1,868,512  
Cash paid during the period for:    
Interest 17,407 11,859
Income taxes 35,778 46,599
Noncash items during the period:    
Changes in unrealized gains and losses on available-for-sale securities, net of tax 101,670 50,344
Distributions of stock from investments (3) $ 34 $ 61,649 [6]
[1] Amounts for the three months ended March 31, 2015, have been revised to reflect the retrospective application of new accounting guidance adopted in the second quarter of 2015 related to our consolidated variable interest entities (ASU 2015-02).
[2] Amounts for the three months ended March 31, 2015, have been revised to reflect the retrospective application of new accounting guidance adopted in the second quarter of 2015 related to our consolidated variable interest entities (ASU 2015-02).
[3] Amounts for the three months ended March 31, 2015, have been revised to reflect the retrospective application of new accounting guidance adopted in the second quarter of 2015 related to our consolidated variable interest entities (ASU 2015-02).
[4] Amounts for the three months ended March 31, 2015, have been revised to reflect the retrospective application of new accounting guidance adopted in the second quarter of 2015 related to our consolidated variable interest entities (ASU 2015-02).
[5] Cash and cash equivalents at March 31, 2015 and December 31, 2014 included $9.3 million and $15.0 million, respectively, recognized in assets held-for-sale in conjunction with the SVBIF sale transaction.
[6] For the quarter ended March 31, 2015, includes distributions to noncontrolling interests of $41.5 million.